According to a report,"Next Generation Sequencing (NGS) Market Size & Forecast By Application (Oncology, Reproductive Health), By Technology (Targeted, WGS, WES ), By Workflow (Data Analysis), By end-use (Academic & Clinical Research), And Trend Analysis, 2018 - 2025", published by Grand View Research, Inc., the global next generation sequencing market is anticipated to reach USD 21.4 billion by 2025. Increasing coverage of NGS is expected to drive use of precision medicine in oncology from research based setting to clinical cancer setting. Commercial payers are also engaged in reviewing the existing and novel tests in order to establish appropriate medical necessity criteria for their clinical and medical policies.
Key Takeaways from the report:
-
Oncology accounted for the dominant share owing to phase-resolved and unambiguous results obtained by using single assay systems, and analysis program.
-
Targeted resequencing dominated the market owing to its associated benefits such as implementation of the technique such as lower turnaround time and more manageable data sets.
-
Academic usage of NGS accounted for the largest share with respect to market revenue by end uses and is anticipated to maintain its dominance.
-
Higher adoption of this technology and platforms in university projects is expected to support the estimated share.
-
Asia Pacific is estimated to witness the fastest growth over the forecast period owing to expected routing of a considerable portion of whole genome sequencing requirements herein.
-
Key players operating in the NGS market include Illumina Inc., Agilent Technologies, BGI, Pacific Biosciences, Qiagen, Roche, Thermo Fischer Scientific, and Oxford Nanopore Technologies Ltd.
-
Endeavors adopted by participants are such as acquisition of Enzymatics by Qiagen acquired solutions in order to enhance the product portfolio with respect to reagents needed in preparatory steps.
UK NGS market revenue, by technology, 2013 - 2024 (USD Million)
Browse More Reports in Biotechnology Industry:
- Tissue Engineering Market: Increasing cases of chronic diseases, road accidents, and trauma injuries is contributing to the growth in development of tissue engineering solutions. In addition, the funding by government for the ongoing research for tissue regeneration is a major driver for market growth.
- Single-Cell Genome Sequencing Market: Emergence of next-generation sequencing (NGS) has helped the market gain tremendous traction over the past few years. Earlier, single-cell genome sequencing market was dominated by PCR and microarray technologies. However, qPCR and NGS are increasingly emerging as the preferred technologies.
Global next generation sequencing market by applications, 2015 & 2025 (USD Million)
Moreover, improved understanding of the genetic markers of virulence and resistance provided by next generation sequencing is expected to drive demand of the technology in infectious disease diagnosis.
Grand View Research has segmented the NGS market on the basis of application, technology, workflow, and end use:
NGS Outlook, by Application (Revenue, USD Million; 2014 - 2025)
-
Reproductive Health
-
NIPT
-
PGT
-
Newborn/Genetic Screening
-
-
Oncology
-
HLA Typing/Immune System Monitoring
-
Metagenomics, Epidemiology & Drug Development
-
Agrigenomics & Forensics
-
Consumer Genomics
-
Clinical Investigation
-
Idiopathic Diseases
-
Inherited Diseases
-
Infectious Diseases
-
Non-Communicable / Other Diseases
-
NGS Outlook, by Technology (Revenue, USD Million; 2014 - 2025)
-
Targeted Sequencing Analysis
-
DNA Based Targeted Sequencing Analysis
-
RNA Based Targeted Sequencing Analysis
-
-
Whole Genome Sequencing
-
Whole Exome Sequencing
NGS Outlook, by Workflow (Revenue, USD Million; 2014 - 2025)
-
Pre-sequencing
-
NGS Library Preparation Kits
-
NGS Semi-automated Library Preparation
-
NGS Automated Library Preparation
-
Clonal Amplification
-
-
Sequencing
-
Data Analysis
-
Primary Data Analysis
-
Secondary Data Analysis
- Tertiary Data Analysis
-
-
NGS Outlook, by End-use (Revenue, USD Million; 2014 - 2025)
-
Academic Research
-
Clinical Research
-
Hospitals & Clinics
-
Pharma & Biotech Entities
-
Other Users
NGS Outlook, by Region (Revenue, USD Million; 2014 - 2025)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
Germany
-
UK
-
-
Asia Pacific
-
China
-
Japan
-
-
Latin America
-
Brazil
-
-
Middle East & Africa
-
South Africa
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
For more information: www.grandviewresearch.com
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email:Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: Switzerland
Website: www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market
